Mild Traumatic Brain Injury Induces Structural and Functional Disconnection of Local Neocortical Inhibitory Networks via Parvalbumin Interneuron Diffuse Axonal Injury

Cereb Cortex. 2018 May 1;28(5):1625-1644. doi: 10.1093/cercor/bhx058.

Abstract

Diffuse axonal injury (DAI) plays a major role in cortical network dysfunction posited to cause excitatory/inhibitory imbalance after mild traumatic brain injury (mTBI). Current thought holds that white matter (WM) is uniquely vulnerable to DAI. However, clinically diagnosed mTBI is not always associated with WM DAI. This suggests an undetected neocortical pathophysiology, implicating GABAergic interneurons. To evaluate this possibility, we used mild central fluid percussion injury to generate DAI in mice with Cre-driven tdTomato labeling of parvalbumin (PV) interneurons. We followed tdTomato+ profiles using confocal and electron microscopy, together with patch-clamp analysis to probe for DAI-mediated neocortical GABAergic interneuron disruption. Within 3 h post-mTBI tdTomato+ perisomatic axonal injury (PSAI) was found across somatosensory layers 2-6. The DAI marker amyloid precursor protein colocalized with GAD67 immunoreactivity within tdTomato+ PSAI, representing the majority of GABAergic interneuron DAI. At 24 h post-mTBI, we used phospho-c-Jun, a surrogate DAI marker, for retrograde assessments of sustaining somas. Via this approach, we estimated DAI occurs in ~9% of total tdTomato+ interneurons, representing ~14% of pan-neuronal DAI. Patch-clamp recordings of tdTomato+ interneurons revealed decreased inhibitory transmission. Overall, these data show that PV interneuron DAI is a consistent and significant feature of experimental mTBI with important implications for cortical network dysfunction.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Action Potentials / physiology
  • Animals
  • Brain Injuries, Traumatic / complications*
  • Brain Injuries, Traumatic / pathology
  • Diffuse Axonal Injury / etiology*
  • Diffuse Axonal Injury / pathology
  • Disease Models, Animal
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glutamate Decarboxylase / metabolism
  • Inhibitory Postsynaptic Potentials / drug effects
  • Inhibitory Postsynaptic Potentials / genetics
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Male
  • Mice
  • Mice, Transgenic
  • Neocortex / pathology*
  • Neocortex / ultrastructure
  • Nerve Tissue Proteins / metabolism
  • Neural Inhibition / genetics
  • Neural Inhibition / physiology*
  • Neural Pathways / pathology*
  • Neural Pathways / ultrastructure
  • Parvalbumins / genetics
  • Parvalbumins / metabolism*
  • Quinoxalines / pharmacology
  • Valine / analogs & derivatives
  • Valine / pharmacology
  • Vesicular Inhibitory Amino Acid Transport Proteins / metabolism

Substances

  • Excitatory Amino Acid Antagonists
  • Luminescent Proteins
  • Nerve Tissue Proteins
  • Parvalbumins
  • Quinoxalines
  • Slc32a1 protein, rat
  • Vesicular Inhibitory Amino Acid Transport Proteins
  • FG 9041
  • 2-amino-5-phosphopentanoic acid
  • Glutamate Decarboxylase
  • glutamate decarboxylase 1
  • Valine